Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ.

Brewster AM, Thomas P, Brown P, Coyne R, Yan Y, Checka C, Middleton L, Do KA, Bevers T.

Cancer Prev Res (Phila). 2018 May;11(5):295-302. doi: 10.1158/1940-6207.CAPR-17-0314. Epub 2018 Apr 4.

2.

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

Trivedi MS, Coe AM, Vanegas A, Kukafka R, Crew KD.

Cancer Prev Res (Phila). 2017 Aug;10(8):434-441. doi: 10.1158/1940-6207.CAPR-17-0100. Epub 2017 Jun 13.

3.

Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.

Port ER, Park A, Borgen PI, Morris E, Montgomery LL.

Ann Surg Oncol. 2007 Mar;14(3):1051-7. Epub 2007 Jan 7.

PMID:
17206485
4.

Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.

Houssami N, Abraham LA, Onega T, Collins LC, Sprague BL, Hill DA, Miglioretti DL.

Breast Cancer Res Treat. 2014 Jun;145(3):765-73. doi: 10.1007/s10549-014-2965-z. Epub 2014 May 7.

5.

Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.

Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW.

Hum Pathol. 1991 Dec;22(12):1232-9.

PMID:
1748429
6.

Diagnosis and Management of High-Risk Breast Lesions.

Thomas PS.

J Natl Compr Canc Netw. 2018 Nov;16(11):1391-1396. doi: 10.6004/jnccn.2018.7099. Review.

PMID:
30442737
8.

Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?

Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C.

Radiology. 2004 Jun;231(3):813-9. Epub 2004 Apr 22.

PMID:
15105449
9.

Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.

Berg WA, Mrose HE, Ioffe OB.

Radiology. 2001 Feb;218(2):503-9.

PMID:
11161169
10.

Lobular carcinoma in situ: observation without surgery as an appropriate therapy.

Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB.

Ann Surg Oncol. 1994 Mar;1(2):141-6.

PMID:
7834439
11.

Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.

Renshaw AA, Gould EW.

Pathology. 2016 Jan;48(1):25-9. doi: 10.1016/j.pathol.2015.11.015. Epub 2015 Dec 14.

PMID:
27020205
12.

Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS).

McEvoy MP, Coopey SB, Mazzola E, Buckley J, Belli A, Polubriaginof F, Merrill AL, Tang R, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi AJ, Roche CA, Hughes KS.

Ann Surg Oncol. 2015 Oct;22(10):3346-9. doi: 10.1245/s10434-015-4747-1. Epub 2015 Aug 5.

PMID:
26242364
13.

Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.

Sen LQ, Berg WA, Hooley RJ, Carter GJ, Desouki MM, Sumkin JH.

AJR Am J Roentgenol. 2016 Nov;207(5):1132-1145. Epub 2016 Aug 17.

PMID:
27532153
14.

When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.

Fives C, O'Neill CJ, Murphy R, Corrigan MA, O'Sullivan MJ, Feeley L, Bennett MW, O'Connell F, Browne TJ.

Breast. 2016 Dec;30:125-129. doi: 10.1016/j.breast.2016.09.006. Epub 2016 Oct 4.

PMID:
27718416
15.

Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.

Cuzick J, Sestak I, Thorat MA.

Breast. 2015 Nov;24 Suppl 2:S51-5. doi: 10.1016/j.breast.2015.07.013.

16.

Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ.

Schwartz T, Cyr A, Margenthaler J.

J Surg Res. 2015 Feb;193(2):519-22. doi: 10.1016/j.jss.2014.08.059. Epub 2014 Sep 4.

PMID:
25277350
17.
18.

Recommendations for women with lobular carcinoma in situ (LCIS).

Oppong BA, King TA.

Oncology (Williston Park). 2011 Oct;25(11):1051-6, 1058. Review.

19.

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.

Vierkant RA, Degnim AC, Radisky DC, Visscher DW, Heinzen EP, Frank RD, Winham SJ, Frost MH, Scott CG, Jensen MR, Ghosh K, Manduca A, Brandt KR, Whaley DH, Hartmann LC, Vachon CM.

BMC Cancer. 2017 Jan 31;17(1):84. doi: 10.1186/s12885-017-3082-2.

20.

Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.

Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN.

Ann Surg Oncol. 2012 Oct;19(10):3131-8. doi: 10.1245/s10434-012-2534-9. Epub 2012 Jul 31.

PMID:
22847124

Supplemental Content

Support Center